Original Research
Accepted on 24 Dec 2025
Protein Kinase C Zeta Promotes Thyroid Cancer Progression and Represents a Novel Therapeutic Target: Evidence from specific atypical PKC inhibitor 2-acetyl-1,3-cyclopentanedione Inhibitor Studies
in Translational Medicine